Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease
The Pharma Data
NOVEMBER 10, 2020
Weiner, chairman of the scientific advisory board of Tiziana Life Sciences, commented: “We understand that this will be the first-ever study with ‘take-home’ capsules of any mAb for immunotherapies for human diseases. Grand View Research August 2018 ( [link] ). NEW YORK and LONDON, Nov. and Europe. Dr. Howard L.
Let's personalize your content